Ulf Harnest

772 total citations
10 papers, 348 citations indexed

About

Ulf Harnest is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Ulf Harnest has authored 10 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Immunology and Allergy. Recurrent topics in Ulf Harnest's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (6 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Ulf Harnest is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (6 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Ulf Harnest collaborates with scholars based in Germany, Hungary and United States. Ulf Harnest's co-authors include Stefan Leichtl, Peter Hofbauer, Dirk Bredenbröker, José Luís Izquierdo Alonso, F. Rathgeb, Andreas Keller, N Vetter, D. Ukena, Péter Magyar and Jean Bousquet and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Allergy.

In The Last Decade

Ulf Harnest

10 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulf Harnest Germany	6	294	245	98	29	28	10	348
Stefan Leichtl Germany	8	297 1.0×	224 0.9×	147 1.5×	33 1.1×	38 1.4×	11	400
Sümeyye Alparslan Bekir Türkiye	5	248 0.8×	223 0.9×	58 0.6×	54 1.9×	29 1.0×	14	352
I.D. Chapman Canada	8	229 0.8×	140 0.6×	82 0.8×	44 1.5×	37 1.3×	13	319
Degenhard Marx Germany	10	153 0.5×	135 0.6×	96 1.0×	30 1.0×	27 1.0×	20	288
Damir Erceg Croatia	9	49 0.2×	53 0.2×	30 0.3×	13 0.4×	24 0.9×	30	235
Sireesh Appajosyula United States	5	252 0.9×	103 0.4×	33 0.3×	210 7.2×	11 0.4×	9	339
A.P. Sykes United Kingdom	13	170 0.6×	162 0.7×	68 0.7×	81 2.8×	3 0.1×	17	423
John Huetsch United States	10	84 0.3×	157 0.6×	176 1.8×	2 0.1×	8 0.3×	19	342
Hiroko Ichiki Japan	4	62 0.2×	30 0.1×	63 0.6×	20 0.7×	27 1.0×	4	142
Claire Brown United States	9	80 0.3×	66 0.3×	119 1.2×		10 0.4×	20	292

Countries citing papers authored by Ulf Harnest

Since Specialization

Citations

This map shows the geographic impact of Ulf Harnest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Harnest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Harnest more than expected).

Fields of papers citing papers by Ulf Harnest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Harnest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Harnest. The network helps show where Ulf Harnest may publish in the future.

Co-authorship network of co-authors of Ulf Harnest

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Harnest. A scholar is included among the top collaborators of Ulf Harnest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Harnest. Ulf Harnest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Harnest, Ulf, David Price, T. Q. Howes, & Gordon Sussman. (2008). Comparison of Mometasone Furoate Dry Powder Inhaler and Fluticasone Propionate Dry Powder Inhaler in Patients with Moderate to Severe Persistent Asthma Requiring High-Dose Inhaled Corticosteroid Therapy: Findings from a Noninferiority Trial. Journal of Asthma. 45(3). 215–220. 9 indexed citations

Richter, Kai, Stephan Stenglein, Marion Mücke, et al.. (2006). Onset and Duration of Action of Formoterol and Tiotropium in Patients with Moderate to Severe COPD. Respiration. 73(4). 414–419. 25 indexed citations

Bateman, Eric D., José Luís Izquierdo Alonso, Ulf Harnest, et al.. (2006). Efficacy and safety of roflumilast in the treatment of asthma. Annals of Allergy Asthma & Immunology. 96(5). 679–686. 71 indexed citations

Bousquet, Jean, Michel Aubier, J. Sastre, et al.. (2005). Comparison of roflumilast, an oral anti‐inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. Allergy. 61(1). 72–78. 80 indexed citations

Harnest, Ulf, LP Boulet, S. Hedgecock, et al.. (2004). Omalizumab, an anti-IgE antibody, improves both asthma- and rhinitis-related quality of life in patients with concomitant moderate-severe disease. Journal of Allergy and Clinical Immunology. 113(2). S176–S176. 3 indexed citations

Bousquet, Jean, et al.. (2003). Omalizumab improves symptom control in patients with porly controlled allergic asthma and concomitant rhinitis. Journal of Allergy and Clinical Immunology. 111(2). S143–S143. 3 indexed citations

Bousquet, Jean, Anthony D’Urzo, Jean‐Louis Hébert, et al.. (2000). Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler. European Respiratory Journal. 16(5). 808–816. 44 indexed citations

Ukena, D., Ulf Harnest, Raimundas Sakalauskas, et al.. (1998). [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma].. PubMed. 52(7). 377–84. 3 indexed citations

Ukena, D., Ulf Harnest, Raimundas Sakalauskas, et al.. (1997). Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. European Respiratory Journal. 10(12). 2754–2760. 109 indexed citations

10.

Harnest, Ulf, et al.. (1989). [Effectiveness and tolerance of the C3 convertase inhibitor, N-acetyl-aspartyl-magnesium glutamate in perennial rhinitis. Results of a double-blind, placebo-controlled study].. PubMed. 39(2). 273–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact